ANIX News and Press, Anixa Biosciences Inc. From 05/02/19

SAN JOSE, Calif. , May 2, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will be presenting at the 20 th Annual B. Riley FBR Institutional Investor Conference t...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

The USPTO has issued Anixa Biosciences (NASDAQ: ANIX ) Patent No. 10,259,855, covering Company's CAR-T cancer treatment technology. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SAN JOSE, Calif. , April 17, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office ("USPTO") has issued US Patent No. 10,259,85...

SAN JOSE, Calif. , April 11, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has extended and expanded its collaboration with New Jersey Urology, LLC ("NJU").  ...

SAN JOSE, Calif. , April 3, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, presented the latest data from its ongoing study on prostate cancer detection, utilizing Cchek™, its artificia...

SAN JOSE, Calif. , March 27, 2019 /PRNewswire/ -- Dr. Amit Kumar , CEO of Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, will participate in a panel presentation discussing the latest science in immunotherapy at ...

SAN JOSE, Calif. , March 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the Hunter Holmes McGuire VA Medical Center (VAMC) located in Richmond, VA has joined it...